Matinas BioPharma Holdings, Inc.·4

Jun 24, 9:00 PM ET

Jabbour Jerome D 4

4 · Matinas BioPharma Holdings, Inc. · Filed Jun 24, 2020

Insider Transaction Report

Form 4
Period: 2020-06-23
Jabbour Jerome D
DirectorPresident and CEO
Transactions
  • Other

    Common Stock, par value $0.0001 per share

    2020-06-23+4,500804,011 total
Footnotes (1)
  • [F1]Stock dividend, payable to all holders of record of Series B Preferred Stock of 300 shares of Common Stock for each share of Series B Preferred Stock.

Documents

1 file
  • 4
    ownership.xmlPrimary